1. Home
  2. Author
  3. Tarka E

Tarka E

References (2)

Title : Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib - Yeo_2017_PLoS.One_12_e0182115
Author(s) : Yeo A , Li L , Warren L , Aponte J , Fraser D , King K , Johansson K , Barnes A , Macphee C , Davies R , Chissoe S , Tarka E , O'Donoghue ML , White HD , Wallentin L , Waterworth D
Ref : PLoS ONE , 12 :e0182115 , 2017
Abstract :
PubMedSearch : Yeo_2017_PLoS.One_12_e0182115
PubMedID: 28753643
Gene_locus related to this paper: human-PLA2G7

Title : Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease - Wallentin_2016_J.Am.Heart.Assoc_5_
Author(s) : Wallentin L , Held C , Armstrong PW , Cannon CP , Davies RY , Granger CB , Hagstrom E , Harrington RA , Hochman JS , Koenig W , Krug-Gourley S , Mohler ER, 3rd , Siegbahn A , Tarka E , Steg PG , Stewart RA , Weiss R , Ostlund O , White HD
Ref : J Am Heart Assoc , 5 : , 2016
Abstract :
PubMedSearch : Wallentin_2016_J.Am.Heart.Assoc_5_
PubMedID: 27329448